Nefrologia 2014;34(5):XXX.
doi10.3265/Nefrologia.pre2014.Jun.12620
Reply to Esteve et al.
Comment on Nefrologia 2014;34(4):xx.
Nefrologia 2014;34(1):69-75.
To the Editor,
We would like to thank Dr. Esteve Simo1 et al. for their interest in our work2 and comments.
We think it is important that studies like theirs reinforce interest in metabolic syndrome in patients on haemodialysis (HD). Although methodologically different, since our main objective was to analyse the effect of metabolic syndrome and to determine the influence of fat mass and conicity index on cardiovascular events in HD and in which a larger number of patients were included, both studies show similar results.
Based on matching the results in both studies and the statistical power of our data, we agree in stating that due to the high prevalence of metabolic syndrome in HD patients, it is necessary to closely monitor these patients to prevent short-term morbidity and that further studies are needed with longer follow-up to analyse long-term mortality.
Conflicts of interest
The authors declare that they have no conflicts of interest related to the contents of this article.
